In summary, our study reveals a novel signaling pathway of circ-ITCH/miR-22-3p/CBL/beta-catenin involved in PTC development and progression.
CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/beta-catenin pathway.